• 1
    Mueller NJ, Fux CA, Ledergerber B et al. Swiss HIV Cohort Study. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010; 24: 11271134.
  • 2
    Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011; 364: 248254.
  • 3
    Pilz S, Tomaschitz A, März W et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011; 75: 575584.
  • 4
    Chapuy MC, Preziosi P, Maamer M et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7: 439443.
  • 5
    Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 19111930.
  • 6
    Olson ML, Maalouf NM, Oden JD, White PC, Hutchison MR. Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab 2012; 97: 279285.
  • 7
    Binkley N, Ramamurthy R, Krueger D. Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am 2010; 39: 287301.
  • 8
    Vescini F, Cozzi-Lepri A, Borderi M et al. Icona Foundation Study Group. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr 2011; 58: 163172.
  • 9
    Viard JP, Souberbielle JC, Kirk O et al. EuroSIDA Study Group. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011; 25: 13051315.
  • 10
    Lake JE, Adams JS. Vitamin D in HIV-infected patients. Curr HIV/AIDS Rep 2011; 8: 133141.
  • 11
    Kayaniyil S, Vieth R, Retnakaran R et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010; 33: 13791381.
  • 12
    Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010: 351385.
  • 13
    Gulseth HL, Gjelstad IM, Tierney AC et al. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care 2010; 33: 923925.
  • 14
    Alvarez JA, Ashraf AP, Hunter GR, Gower BA. Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr 2010; 92: 13441349.
  • 15
    Karnchanasorn R, Ou HY, Chiu KC. Plasma 25-hydroxyvitamin D levels are favorably associated with β-cell function. Pancreas 2012; 41: 863868.
  • 16
    Szep Z, Guaraldi G, Shah SS et al. Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. AIDS 2011; 25: 525529.
  • 17
    Van den Bout-van den Beukel CJ, van den Bos M, Oyen WJ et al. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin d-deficient HIV-1-infected patients. HIV Med 2008; 9: 771779.
  • 18
    Longenecker CT, Hileman CO, Carman TL et al. Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 2012; 17: 613621.
  • 19
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35 (Suppl 1): S64S71.
  • 20
    Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 5763.
  • 21
    DeFronzo RA, Abdul-Ghani MA. Preservation of β-cell function: the key to diabetes prevention. J Clin Endocrinol Metab 2011; 96: 23542366.
  • 22
    Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG, HIV Lipodystrophy Case Definition Study Group. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003; 361: 726735.
  • 23
    Szczepaniak LS, Nurenberg P, Leonard D et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462E468.
  • 24
    Hosker JP, Matthews DR, Rudenski AS et al. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia 1985; 28: 401411.
  • 25
    Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 1999; 48: 17791786.
  • 26
    Barengolts E. Vitamin D role and use in prediabetes. Endocr Pract 2010; 16: 476485.
  • 27
    Hammond E, McKinnon E, Glendenning P, Williams R, Mallal S, Phillips E. Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clin Endocrinol (Oxf) 2012; 76: 201206.
  • 28
    Pittas AG, Nelson J, Mitri J et al. the Diabetes Prevention Program Research Group. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 2012; 35: 565573.
  • 29
    Kayaniyil S, Retnakaran R, Harris SB et al. Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 2011; 60: 29472953.
  • 30
    Guaraldi G, Zona S, Orlando G et al. Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 18th Conference on Retroviruses and Opportunistic Infections. Boston, Massachusetts, DC [Abstract A827]. Available at (accessed 20 July 2012).